Kuo-Cheng Lan

Dr. Kuo-Cheng Lan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CHChun-Fa Huang
Chun-Fa Huang
CYChing-Yao Yang
Ching-Yao Yang
JTJing-Ren Tsai
Jing-Ren Tsai
CWCheng-Tien Wu
Cheng-Tien Wu
SLShing-Hwa Liu
Shing-Hwa Liu
KLKuo-Cheng Lan
Kuo-Cheng Lan
Tributyltin (TBT), an endocrine disrupting chemical, can be found in food (particular in fish and seafood) and drinking water by contamination. Here, we elucidated the effects and possible mechanisms of low-dose TBT on the growth and function of pancreatic β-cells and glucose metabolism in mice. Submicromolar-concentration of TBT significantly induced β-cell cytotoxicity and apoptosis, which were accompanied by poly (ADP-ribose) polymerase cleavage and mitogen-activated protein kinases-JNK and ERK1/2 phosphorylation. TBT could also suppress the glucose-stimulated insulin secretion in β-cells and isolated mouse islets. TBT increased reactive oxygen species production. TBT-induced β-cell cytotoxicity and apoptosis were significantly prevented by antioxidant N-acetylcysteine (NAC) and JNK inhibitor SP600125, but not ERK1/2 inhibitor PD98059 and p38 inhibitor SB203580. Both NAC and SP600125 inhibited JNK phosphorylation and reduced cell viability in TBT-treated β-cells. Four-week exposure of TBT (0.25 mg/kg) to mice revealed the decreased plasma insulin, increased blood glucose and plasma malondialdehyde, suppressed islet insulin secretion, and increased islet caspase-3 activity, which could be reversed by NAC treatment. After removing the TBT exposure for 2 weeks, the TBT-induced glucose metabolism alteration was significantly reversed. These results suggest that low-dose TBT can induce β-cell apoptosis and interfere with glucose homeostasis via an oxidative stress-related pathway.

2 September 2021 in Toxins
Verified
Journal Article
Open access
PDF file
CHCheng-Hsuan Ho
Cheng-Hsuan Ho
LCLiao-Chun Chiang
Liao-Chun Chiang
Yan-Chiao MaoYan-Chiao Mao
Yan-Chiao Mao
KLKuo-Cheng Lan
Kuo-Cheng Lan
STShih-Hung Tsai
Shih-Hung Tsai
SLShing-Hwa Liu
Shing-Hwa Liu
Patients bitten by Naja atra who are treated with bivalent freeze-dried neurotoxic antivenom in Taiwan have an improved survival rate but develop necrotic wound changes. The World Health Organization (WHO) has suggested using the minimum necrotizing dose (MND) of venom as a method of evaluating the neutralization effect of antivenom. The aim of this study was to evaluate the effectiveness of antivenom for the prevention of necrosis based on the MND and clarify which component of the venom of N. atra induces necrosis. The neurotoxins (NTXs) were removed from the crude venom (deNTXs), and different concentrations of deNTXs were injected intradermally into the dorsal skin of mice. After three days, the necrotic lesion diameter was found to be approximately 5 mm, and the MND was calculated. A reduction in the necrotic diameter of 50% was used to identify the MND50. Furthermore, both phospholipase A2 (PLA2) and cytotoxins (CTXs) were separately removed from the deNTXs to identify the major necrosis-inducing factor, and the necrotic lesions were scored. All mice injected with deNTXs survived for three days and developed necrotic wounds. The MND of the deNTXs for mice was 0.494 ± 0.029 µg/g, that of the deNTXs-dePLA2 (major component retained: CTXs) was 0.294 ± 0.05 µg/g, and that of the deNTX-deCTX (major component retained: PLA2) venom was greater than 1.25 µg/g. These values show that CTX is the major factor inducing necrosis. These results suggest that the use of the deNTXs is necessary to enable the mice to survive long enough to develop venom-induced cytolytic effects. CTXs play a major role in N. atra-related necrosis. However, the MND50 could not be identified in this study, which meant that the antivenom did not neutralize venom-induced necrosis.

4 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
CCChang-Mu Chen
Chang-Mu Chen
MCMin-Ni Chung
Min-Ni Chung
CCChen-Yuan Chiu
Chen-Yuan Chiu
SLShing-Hwa Liu
Shing-Hwa Liu
KLKuo-Cheng Lan
Kuo-Cheng Lan
Arsenic is a toxic metalloid. Infants with a low birth-weight have been observed in areas with high-level arsenic in drinking water ranging from 463 to 1025 μg/L. A distal muscular atrophy side effect has been observed in acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3) for therapy. The potential of As2O3 on muscle atrophy remains to be clarified. In this study, the myoatrophic effect of arsenic was evaluated in normal mice and sciatic nerve denervated mice exposed with or without As2O3 (0.05 and 0.5 ppm) in drinking water for 4 weeks. We found that both 0.05 and 0.5 ppm As2O3 increased the fasting plasma glucose level; but only 0.5 ppm arsenic exposure significantly decreased muscle mass, muscle endurance, and cross-sectional area of muscle fibers, and increased muscle Atrogin-1 protein expression in the normal mice. Both 0.05 and 0.5 ppm As2O3 also significantly enhanced the inhibitory effects on muscle endurance, muscle mass, and cross-sectional area of muscle fibers, and increased the effect on muscle Atrogin-1 protein expression in the denervated mice. These in vivo results suggest that inorganic arsenic at doses relevant to humans may possess myoatrophic potential.

1 August 2021 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
PTPei-Shan Tsai
Pei-Shan Tsai
CCChen-Yuan Chiu
Chen-Yuan Chiu
MSMeei-Ling Sheu
Meei-Ling Sheu
CYChing-Yao Yang
Ching-Yao Yang
KLKuo-Cheng Lan
Kuo-Cheng Lan
SLShing-Hwa Liu
Shing-Hwa Liu

1 October 2019 in Vascular Pharmacology
Verified
Journal Article
Closed access
HTHuei-Ping Tzeng
Huei-Ping Tzeng
TYTing-Hua Yang
Ting-Hua Yang
CWCheng-Tien Wu
Cheng-Tien Wu
HCHsien-Chun Chiu
Hsien-Chun Chiu
SLShing-Hwa Liu
Shing-Hwa Liu
KLKuo-Cheng Lan
Kuo-Cheng Lan

Verified
Journal Article
Open access
PDF file
CWChing-Chia Wang
Ching-Chia Wang
CCCarlos Chen
Carlos Chen
CDChan Ding-Cheng
Chan Ding-Cheng
CCChen-Yuan Chiu
Chen-Yuan Chiu
SLShing-Hwa Liu
Shing-Hwa Liu
KLKuo-Cheng Lan
Kuo-Cheng Lan
Urinary acrolein adduct levels have been reported to be increased in both habitual smokers and type-2 diabetic patients. The impairment of glucose transport in skeletal muscles is a major factor responsible for glucose uptake reduction in type-2 diabetic patients. The effect of acrolein on glucose metabolism in skeletal muscle remains unclear. Here, we investigated whether acrolein affects muscular glucose metabolism in vitro and glucose tolerance in vivo. Exposure of mice to acrolein (2.5 and 5 mg/kg/day) for 4 weeks substantially increased fasting blood glucose and impaired glucose tolerance. The glucose transporter-4 (GLUT4) protein expression was significantly decreased in soleus muscles of acrolein-treated mice. The glucose uptake was significantly decreased in differentiated C2C12 myotubes treated with a non-cytotoxic dose of acrolein (1 μM) for 24 and 72 h. Acrolein (0.5–2 μM) also significantly decreased the GLUT4 expression in myotubes. Acrolein suppressed the phosphorylation of glucose metabolic signals IRS1, Akt, mTOR, p70S6K, and GSK3α/β. Over-expression of constitutive activation of Akt reversed the inhibitory effects of acrolein on GLUT4 protein expression and glucose uptake in myotubes. These results suggest that acrolein at doses relevant to human exposure dysregulates glucose metabolism in skeletal muscle cells and impairs glucose tolerance in mice.